Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retrovital vector particles

Virology

Volumn 261, Issue 1, 1999, Pages 70-78

  Höhne, Martin ^a   Thaler, Sonja ^b   Dudda, Jan C ^a   Groner, Bernd ^a,b   Schnierle, Barbara S ^a,b  

^a TUMOR BIOLOGY CENTER   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOPLASM; FRAMESHIFT MUTATION; GENE TARGETING; GENE THERAPY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS PARTICLE; VIRUS TYPING;

EID: 0344604524     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9847     Document Type: Article

References (27)

1. Berlioz-Torrent C., Shacklett B. L., Erdtmann L., Delamarre L., Bouchaert I., Sonigo P., Dokhelar M. C., Benarous R. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J. Virol. 73:1999;1350-1361.
2. Burns J. C., Friedmann T., Driever W., Burrascano M., Yee J. K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA. 90:1993;8033-8037.
3. Chakrabarti L., Emerman M., Tiollais P., Sonigo P. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J. Virol. 63:1989;4395-4403.
4. Chakrabarti L., Guyader M., Alizon M., Daniel M. D., Desrosiers R. C., Tiollais P., Sonigo P. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 328:1987;543-547.
5. Chesebro B., Wehrly K., Maury W. Differential expression in human and mouse cells of human immunodeficiency virus pseudotyped by murine retroviruses. J. Virol. 64:1990;4553-4557.
6. Cosset F. L., Takeuchi Y., Battini J. L., Weiss R. A., Collins M. K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:1995;7430-7436.
7. Deng H. K., Unutmaz D., KewalRamani V. N., Littman D. R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388:1997;296-300.
8. Franchini G., Fargnoli K. A., Giombini F., Jagodzinski L., De Rossi A., Bosch M., Biberfeld G., Fenyo E. M., Albert J., Gallo R. C. Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc. Natl. Acad. Sci. USA. 86:1989;2433-2437.
9. Henriksson P., Bosch V. Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of an additional cellular interaction partner. Virology. 251:1998;16-21.
10. Hirsch V. M., Edmondson P., Murphey-Corb M., Arbeille B., Johnson P. R., Mullins J. I. SIV adaptation to human cells. Nature. 341:1989;573-574.
11. Hunter E., Swanstrom R. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157:1990;187-253.
12. Indraccolo S., Minuzzo S., Feroli F., Mammano F., Calderazzo F., Chieco-Bianchi L., Amadori A. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Gene Ther. 5:1998;209-217.
13. Kong L. I., Lee S. W., Kappes J. C., Parkin J. S., Decker D., Hoxie J. A., Hahn B. H., Shaw G. M. West African HIV-2-related human retrovirus with attenuated cytopathicity. Science. 240:1988;1525-1529.
14. Mulligan M. J., Yamshchikov G. V., Ritter G. D. Jr., Gao F., Jin M. J., Nail C. D., Spies C. P., Hahn B. H., Compans R. W. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:1992;3971-3975.
15. Mammano F., Salvatori F., Indraccolo S., De Rossi A., Chieco-Bianchi L., Gottlinger H. G. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J. Virol. 71:1997;3341-3345.
16. Naidu Y. M., Kestler H. W. d., Li Y., Butler C. V., Silva D. P., Schmidt D. K., Troup C. D., Sehgal P. K., Sonigo P., Daniel M. D. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: Persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62:1988;4691-4696.
17. Pear W. S., Nolan G. P., Scott M. L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
18. Pfitzner E., Becker P., Rolke A., Schule R. Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions. Proc. Natl. Acad. Sci. USA. 92:1995;12265-12269.
19. Porter C. D., Collins M. K., Tailor C. S., Parkar M. H., Cosset F. L., Weiss R. A., Takeuchi Y. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum. Gene Ther. 7:1996;913-919.
20. Schnierle B. S., Moritz D., Jeschke M., Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3:1996;334-342.
21. Schnierle B. S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstadter M., Kurth R., Groner B., Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA. 94:1997;8640-8645.
22. Soneoka Y., Cannon P. M., Ramsdale E. E., Griffiths J. C., Romano G., Kingsman S. M., Kingsman A. J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:1995;628-633.
23. Suomalainen M., Garoff H. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J. Virol. 68:1994;4879-4889.
24. Takeuchi Y., Cosset F. L., Lachmann P. J., Okada H., Weiss R. A., Collins M. K. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68:1994;8001-8007.
25. Trowbridge I. S., Collawn J. F., Hopkins C. R. Signal-dependent membrane protein trafficking in the endocytic pathway. Annu. Rev. Cell Biol. 9:1993;129-161.
26. Unutmaz D., KewalRamani V. N., Littman D. R. G protein-coupled receptors in HIV and SIV entry: New perspectives on lentivirus-host interactions and on the utility of animal models. Semin. Immunol. 10:1998;225-236.
27. Wilson C., Reitz M. S., Okayama H., Eiden M. V. Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus. J. Virol. 63:1989;2374-2378.